Am. J. Respir. Crit. Care Med., Volume 162, Number 2, August 2000, 553-558

Occupational Exposure Risks in Individuals with PI*Z ₁-Antitrypsin Deficiency

ANNYCE S. MAYER, JAMES K. STOLLER, BECKI BUCHER BARTELSON, A. JAMES RUTTENBER, ROBERT A. SANDHAUS, and LEE S. NEWMAN

Division of Environmental and Occupational Health Sciences and Pulmonary Division, Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado; Division of Pulmonary and Critical Care Sciences, Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado; and Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

We obtained questionnaire and spirometry data from 128 ₁-antitrypsin (₁AT)-deficient individuals with phenotype PI*Z to examine the relationship between chronic respiratory symptoms, airflow limitation, treatment requirements, and semiquantitative estimates of occupational exposure to dust, fumes, smoke, and gas. After adjusting for age, smoking, and prior lower respiratory tract infections, increased prevalence of chronic cough (OR = 4.69, 95% CI = 1.57-13.74, p = 0.006) and having left a job due to breathlessness (OR = 2.72, 95% CI = 1.07-6.92, p = 0.036) were seen in individuals reporting high mineral dust exposure compared with those with no exposure. Subjects reporting high mineral dust exposure also had significantly lower FEV₁ (31% predicted for high exposure versus 36% for low and 40% for unexposed, p = 0.032). The excess risk of chronic cough seen with occupational fumes or smoke exposure disappeared after adjusting for mineral dust exposure, but the association with lower FEV₁/FVC ratio persisted (p = 0.022). Personal tobacco use was a significant risk factor for most outcome measures, but no interaction with occupational exposure was seen. These results suggest that occupational inhalational exposures are independently associated with respiratory symptoms and airflow limitation in severely ₁AT-deficient individuals.

This article has been cited by other articles:

				J. Prins, B. B. van der Meijden, R. J. Kraaijenhagen, and J. P.M. Wielders Inherited Chronic Obstructive Pulmonary Disease: New Selective-Sequencing Workup for {alpha}1-Antitrypsin Deficiency Identifies 2 Previously Unidentified Null Alleles Clin. Chem., January 1, 2008; 54(1): 101 - 107. [Abstract] [Full Text] [PDF]

				M. Brantly Efficient and Accurate Approaches to the Laboratory Diagnosis of {alpha}1-Antitrypsin Deficiency: The Promise of Early Diagnosis and Intervention Clin. Chem., December 1, 2006; 52(12): 2180 - 2181. [Full Text] [PDF]

				C. Strange, M. A. Moseley, Y. Jones, L. Schwarz, L. Xie, and M. L. Brantly Genetic Testing of Minors for Alpha1-Antitrypsin Deficiency Arch Pediatr Adolesc Med, May 1, 2006; 160(5): 531 - 534. [Abstract] [Full Text] [PDF]

				O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch {alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants Eur. Respir. J., November 1, 2005; 26(5): 909 - 917. [Abstract] [Full Text] [PDF]

				J. K. Stoller, R. A. Sandhaus, G. Turino, R. Dickson, K. Rodgers, and C. Strange Delay in Diagnosis of {alpha}1-Antitrypsin Deficiency: A Continuing Problem Chest, October 1, 2005; 128(4): 1989 - 1994. [Abstract] [Full Text] [PDF]

				E. Piitulainen, J. Carlson, K. Ohlsson, and T. Sveger {alpha}1-Antitrypsin Deficiency in 26-Year-Old Subjects: Lung, Liver, and Protease/Protease Inhibitor Studies Chest, October 1, 2005; 128(4): 2076 - 2081. [Abstract] [Full Text] [PDF]

				J. K. Stoller, J. Tomashefski Jr, R. G. Crystal, A. Arroliga, C. Strange, D. N. Killian, M. D. Schluchter, H. P. Wiedemann, and for the {alpha}1-Antitrypsin Deficiency Registry S Mortality in Individuals With Severe Deficiency of {alpha}1-Antitrypsin: Findings From the National Heart, Lung, and Blood Institute Registry Chest, April 1, 2005; 127(4): 1196 - 1204. [Abstract] [Full Text] [PDF]

				R A Sandhaus {alpha}1-Antitrypsin deficiency {middle dot} 6: New and emerging treatments for {alpha}1-antitrypsin deficiency Thorax, October 1, 2004; 59(10): 904 - 909. [Abstract] [Full Text] [PDF]

				M Needham and R A Stockley {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history Thorax, May 1, 2004; 59(5): 441 - 445. [Abstract] [Full Text] [PDF]

				American Thoracic Society Statement: Occupational Contribution to the Burden of Airway Disease Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 787 - 797. [Full Text] [PDF]

				A J Sandford and E K Silverman Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction Thorax, August 1, 2002; 57(8): 736 - 741. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF]